Pharma.Aero welcomes pharmaceutical shippers and other key air cargo stakeholders
Pharma.Aero welcomes an additional eight companies into the organization,including pharmaceutical shippers Pfizer, Johnson and Johnson, Merck Sharp & Dohme.
May 1, 2017
By Kelsea Koh
Pharma.Aero welcomes an additional eight companies into the organization. Among them are pharmaceutical shippers Pfizer, Johnson and Johnson, Merck Sharp & Dohme, as well as other air cargo stakeholders which comprises of DHL Temperature Management Solutions, Expeditors, EuroAirport Basel, 4Advice and e-CARGOWARE. This brings the total number of companies in Pharma.Aero to sixteen members. Nathan De Valck, Chairman of Pharma.Aero, said: “Within a short span of six months, Pharma.Aero has achieved our top priority of expanding the membership base to other stakeholders in the pharmaceutical supply chain. The recent addition of the three global pharmaceuticals shippers marks a significant milestone to the organisation as we will be able to collaborate closely with the pharmaceutical shippers on projects to achieve a reliable end to-end air transport for pharmaceutical cargo. Together with the air cargo stakeholders, we will develop global pharmaceutical trade lanes, implement best practices and share market knowledge and expertise. Pharma.Aero welcomes other IATA CEIV airport communities, shippers, airline carriers, logistics companies, and other pharmaceutical stakeholders with like-minded goals to become members.”
“As board member of Pharma.Aero, Pfizer hopes to be actively involved in the continuous growth of Pharma.Aero. The platform will support longer term projects and initiatives, which would benefit all pharma transportation players, regulators and shippers, ensuring high pharma product compliance and visibility in the air supply chain” said Eddy Weygaerts, senior manager, Logistics Delivery, ELC & ES EU, Pfizer.
About Pharma.Aero: The worldwide Pharma.Aero platform will enable its members consisting of Airport Communities, Pharma Shippers, and other pharma logistics stakeholders to foster strong collaboration amongst themselves. By sharing expertise, data, best practices and jointly working on innovative regional initiatives with an emphasis on the IATA CEIV Program, airports and their operators will achieve excellence in reliable end to end transportation for the pharma shippers and patients.